13/12/2024 (Agence Europe) – On Friday 13 December, the European Commission authorised, under EU State aid rules, €52 million of Slovenian aid to help Lek Pharmaceuticals build a new high-tech facility in Lendava for the production of biological active substances. The measure will contribute to the supply of affordable medicines in line with the Pharmaceutical Strategy for Europe. In addition, the Commission has approved Finnish support worth €400 million to help companies...